{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:08Z","timestamp":1761100988913},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1038\/sj.bjc.6604608","type":"journal-article","created":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T13:48:07Z","timestamp":1222177687000},"page":"S113-S115","source":"Crossref","is-referenced-by-count":2,"title":["Survival from multiple myeloma in England and Wales up to 2001"],"prefix":"10.1038","volume":"99","author":[{"given":"S","family":"Schey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,23]]},"reference":[{"key":"BF6604608_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1470-2045(03)01076-3","volume":"4","author":"AJ Ashcroft","year":"2003","unstructured":"Ashcroft AJ, Davies FE, Morgan GJ (2003) Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. Lancet 4: 284\u2013292","journal-title":"Lancet"},{"key":"BF6604608_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Paven C, Bataille R (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Eng J Med 335: 91\u201397","journal-title":"N Eng J Med"},{"key":"BF6604608_CR3","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1200\/JCO.2002.20.5.1295","volume":"20","author":"A Badros","year":"2002","unstructured":"Badros A, Barlogie B, Siegel E, Cottier-Fox M, Zangari M, Fassas A, Morris C, Anaissie E, Van Rhee F, Tricot G (2002) Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. J Clin Oncol 20: 1295\u20131301","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1200\/JCO.2005.04.5807","volume":"24","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Kyle RA, Anderson KC, Greipp PR, Lazarus HM, Hurd DD, McCoy J, Moore Jr DF, Dakhil SR, Lanier KS, Chapman RA, Cromer JN, Salmon SE, Durie B, Crowley JC (2006) Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. J Clin Oncol 24: 929\u2013936","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR5","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","volume":"88","author":"BB Bjorkstrand","year":"1996","unstructured":"Bjorkstrand BB, Ljungman P, Svensson H, Hermans J, Alegre A, Apperley J, Blade J, Carlson K, Cavo M, Ferrant A, Goldstone AH, de Laurenzi A, Majoline I, Marcus R, Prentice HG, Remes K, Samson D, Sureda A, Verdonck LF, Volin L, Gahrton G (1996) Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 88: 4711\u20134718","journal-title":"Blood"},{"key":"BF6604608_CR6","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1182\/blood-2005-03-1301","volume":"106","author":"J Blade","year":"2005","unstructured":"Blade J, Rosinol L, Sureda A, Ribera JM, Diaz-Mediavilla J, Garcia-Larana J, Mateos MV, Palomera L, Fernandez-Calvo J, Marti JM, Giraldo P, Carbonell F, Callis M, Trjillo J, Gardella S, Moro MJ, Barez A, Soler A, Font L, Fontanillas M, San Miguel J, Programa para el Estudio de la Terapeutica en Hemopatia Maligna (PETHEMA) (2005) High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA. Blood 106: 3755\u20133759","journal-title":"Blood"},{"key":"BF6604608_CR7","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1200\/JCO.1996.14.7.2167","volume":"14","author":"J Blade","year":"1996","unstructured":"Blade J, San Miguel JF, Fontanillas M, Alcala A, Maldonado J, Garcia-Conde J, Conde E, Conzalez-Brito G, Moro MJ, Escudero ML, Trujillo J, Pascual A, Rozman C, Estape J, Montserrat E (1996) Survival of multiple myeloma patients who are potential candidates for early high-dose the intensification\/ autotransplantation and who were conventionally treated. J Clin Oncol 14: 2167\u20132173","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR8","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1182\/blood-2007-08-104984","volume":"111","author":"H Brenner","year":"2008","unstructured":"Brenner H, Gondos A, Pulte D (2008) Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 111: 2521\u20132526","journal-title":"Blood"},{"key":"BF6604608_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1056\/NEJMoa065464","volume":"356","author":"B Bruno","year":"2007","unstructured":"Bruno B, Rotta M, Patriarca F, Mordini N, Allione B, Carnevale-Schianca F, Glaccone L, Sorasio R, Omede P, Baldi I, Bringhen S, Massala M, Aglietta M, Levis A, Gallamini A, Fanin R, Palumbo A, Storb R, Ciccone G, Boccadoro M (2007) A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med 356: 1110\u20131120","journal-title":"N Engl J Med"},{"key":"BF6604608_CR10","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1182\/blood-2006-09-046409","volume":"109","author":"AA Chanan-Khan","year":"2007","unstructured":"Chanan-Khan AA, Kaufman JL, Mehta J, Richardson PG, Miller KC, Lonial S, Munshi NC, Sclossman R, Tariman J, Singhal S (2007) Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study. Blood 109: 2604\u20132606","journal-title":"Blood"},{"key":"BF6604608_CR11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","volume":"87","author":"D Chauhan","year":"1996","unstructured":"Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K, Libermann TA, Anderson KC (1996) Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood 87: 1104\u20131112","journal-title":"Blood"},{"key":"BF6604608_CR12","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brwon J, Drayson MT, Selby PJ, Medical Research Council Adult Leukaemia Working Party (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348: 1875\u20131883","journal-title":"N Engl J Med"},{"key":"BF6604608_CR13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","volume":"163","author":"LG Corral","year":"1999","unstructured":"Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163: 380\u2013386","journal-title":"J Immunol"},{"key":"BF6604608_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood.V98.1.210","volume":"98","author":"FE Davies","year":"2001","unstructured":"Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT, Lin B, Podar K, Gupta D, Chauhan D, Treon SP, Richardson PG, Schlossman RL, Morgan GJ, Muller GW, Stirling DI, Anderson KC (2001) Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood 98: 210\u2013216","journal-title":"Blood"},{"key":"BF6604608_CR15","first-page":"6","volume":"106","author":"MA Dimopoulos","year":"2005","unstructured":"Dimopoulos MA, Spencer A, Attal M, Prince M, Harousseau J-L, Dmoszynska A, Yu Z, Olesnyckyj M, Zeldis J, Knight R (2005) Study of lenalidomide plus dexamethasone versus dexamethasone alone in relapsed or refractory multiple myeloma (MM): results of a phase 3 study (MM-010). Blood (ASH Annual Meeting Abstracts), Nov 106: 6","journal-title":"Blood (ASH Annual Meeting Abstracts), Nov"},{"key":"BF6604608_CR16","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.4049\/jimmunol.168.10.4914","volume":"168","author":"K Dredge","year":"2002","unstructured":"Dredge K, Marriott JB, Todryk SM, Muller GW, Chen R, Stirling DI, Dalgleish AG (2002) Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity. J Immunol 168: 4914\u20134919","journal-title":"J Immunol"},{"key":"BF6604608_CR17","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood.V92.9.3131","volume":"92","author":"JP Fermand","year":"1998","unstructured":"Fermand JP, Ravaud P, Chevret S, Divine M, Leblond V, Belanger C, Macro M, Pertuiset E, Dreyfus F, Mariette X, Boccacio C, Brouet JC (1998) High-dose therapy and autologous peripheral blood stem-cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized trial. Blood 92: 3131\u20133136","journal-title":"Blood"},{"key":"BF6604608_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","volume":"113","author":"G Gahrton","year":"2001","unstructured":"Gahrton G, Svensson H, Cavo M, Apperly J, Bacigalupo A, Bj\u00f6rkstrand B, Blad\u00e9 J, Cornelissen J, de Laurenzi A, Facon T, Ljungman P, Michallet M, Niederwieser D, Powles R, Reiffers J, Russell NH, Samson D, Schaefer UW, Schattenberg A, Tura S, Verdonck LF, Vernant JP, Willemze R, Volin L, European Group for Blood and Marrow Transplantation (2001) Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983\u201393 and 1994\u201398 at European Group for Blood and Marrow Transplantation centers. Br J Haematol 113: 209\u2013216","journal-title":"Br J Haematol"},{"key":"BF6604608_CR19","unstructured":"Gahrton G, Tura S, Svensson H (1997) Allogeneic bone marrow transplantation in multiple myeloma: an update of the EBMT registry. Sixth International Workshop on multiple myeloma. Syllabus, Boston, MA, 1997, June 14\u201318. Harvard Medical School: Boston"},{"key":"BF6604608_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2141.2002.03440.x","volume":"117","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A, Accreditation Committee of the European group for Blood and Bone Marrow Transplantation (EBMT) (2002) Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol 117: 451\u2013468","journal-title":"Br J Haematol"},{"key":"BF6604608_CR21","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/sj.leu.2402295","volume":"15","author":"D Gupta","year":"2001","unstructured":"Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI, Anderson KC (2001) Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 15: 1950\u20131961","journal-title":"Leukemia"},{"key":"BF6604608_CR22","first-page":"1654","volume":"98","author":"KC Kose","year":"2006","unstructured":"Kose KC, Cebesoy O, Akan B, Altinel L, Dincer D, Yazar T (2006) Functional results of vertebral augmentation techniques in pathological vertebral fracture of myelomatous patients. J Natl Med Assoc 98: 1654\u20131658","journal-title":"J Natl Med Assoc"},{"key":"BF6604608_CR23","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bjorkholm M (2007) Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 25: 1993\u20131999","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0140-6736(92)90004-M","volume":"339","author":"ICM MacLennan","year":"1992","unstructured":"MacLennan ICM, Chapman C, Dunn J, Kelly K (1992) Combined chemotherapy with ABCM versus mephalan for treatment of myelomatosis. Lancet 339: 200\u2013205","journal-title":"Lancet"},{"key":"BF6604608_CR25","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1200\/JCO.1997.15.7.2644","volume":"15","author":"JM Mitchell","year":"1997","unstructured":"Mitchell JM, Meehan KR, Kong J, Schulman KA (1997) Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol 15: 2644\u20132651","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.beha.2007.09.008","volume":"20","author":"CS Mitsiades","year":"2007","unstructured":"Mitsiades CS, Hayden PJ, Anderson KC, Richardson PG (2007) From the bench to the bedside: emerging new treatments in multiple myeloma. Best Pract Res Clin Haematol 20: 707\u2013816","journal-title":"Best Pract Res Clin Haematol"},{"key":"BF6604608_CR27","first-page":"972","volume":"91","author":"AP Ng","year":"2006","unstructured":"Ng AP, Wei A, Bhurani D, Chapple P, Fellepa F, Juneja S (2006) The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Haematologica 91: 972\u2013975","journal-title":"Haematologica"},{"key":"BF6604608_CR28","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1200\/JCO.2002.99.151","volume":"20","author":"KS Peggs","year":"2002","unstructured":"Peggs KS, Mackinnon S, Yong K (2002) Reduced intensity conditioning and allogeneic stem-cell transplantation: determining its role in multiple myeloma. J Clin Oncol 20: 4268","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2141.2004.05207.x","volume":"127","author":"KJ Phekoo","year":"2004","unstructured":"Phekoo KJ, Schey SA, Richards MA, Bevan DH, Gillett D, M\u00f8ller H (2004) A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in the United Kingdom. Br J Haematol 127: 299\u2013304","journal-title":"Br J Haematol"},{"key":"BF6604608_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.blre.2007.01.002","volume":"21","author":"SV Rajkumar","year":"2007","unstructured":"Rajkumar SV, Lacey MO, Kyle RA (2007) Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Blood Rev 21: 255\u2013265","journal-title":"Blood Rev"},{"key":"BF6604608_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1200\/JCO.2005.11.030","volume":"23","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Richardson PG, Hideshima T, Anderson KC (2005) Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol 23: 630\u2013639","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR32","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1182\/blood-2002-03-0996","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Schlossman RL, Weller E, Hideshima T, Mitsiades C, Davies F, LeBalnc R, Catley LP, Doss D, Kelly K, McKenney M, Mechlowicz J, Freeman A, Deocampo R, Rich R, Ryoo JJ, Chauhan D, Balinski K, Zeldis J, Anderson KC (2002) Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood 100: 3063\u20133067","journal-title":"Blood"},{"key":"BF6604608_CR33","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1200\/JCO.2004.10.052","volume":"22","author":"SA Schey","year":"2004","unstructured":"Schey SA, Fields P, Bartlett JB, Clarke IA, Ashan G, Knight RD, Streetly M, Dalgleish AG (2004) Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma. J Clin Oncol 22: 3269\u20133276","journal-title":"J Clin Oncol"},{"key":"BF6604608_CR34","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1136\/bmj.1.5399.1664","volume":"1","author":"DE Speed","year":"1964","unstructured":"Speed DE, Galton DA, Swan A (1964) Melphalan in the treatment of myelomatosis. Br Med J 1: 1664\u20131669","journal-title":"Br Med J"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604608.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604608","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604608.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T01:53:38Z","timestamp":1684547618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":34,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["BF6604608"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604608","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}